Bristol Myers Squibb BMY announced that it has obtained a positive opinion from the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency for two of its drugs. The ...

In an invited talk at the upcoming Tandem meetings, Dr. Megan Herr of Roswell Park Comprehensive Cancer Center will highlight the link between patients' physical function and CAR T outcomes; Dr.

Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

In a challenging market environment, C4 Therapeutics Inc. stock has touched a new 52-week low, reaching a price level of $3.38. With a beta of 2.97, the stock's high volatility is evident in its price ...